Background— Phase 1 clinical trials of granulocyte-colony stimulating factor (G-CSF) treatment
after myocardial infarction have indicated that G-CSF treatment is safe and may improve …

Objective: To investigate the spontaneous occurrence of circulating mesenchymal stem
cells (MSC) and angiogenic factors in patients with ST elevation acute myocardial infarction (…

The brains of teleost fish show extensive adult neurogenesis and neuronal regeneration.
The patterns of gene regulation during fish brain aging are unknown. The short‐lived teleost …

Background— Granulocyte-colony stimulating factor (G-CSF) after myocardial infarction does
not affect systolic function when compared with placebo. In contrast, intracoronary infusion …

Objective— A feature of vulnerable atherosclerotic plaques of the carotid artery is high activity
and abundance of lesion macrophages. There is consensus that this is of importance for …

Aims To assess the safety and effects of combined treatment with vascular endothelial
growth factor-A 165 plasmid (VEGF-A 165 ) and granulocyte- colony stimulating factor (G-CSF) …

Background. YKL-40 is involved in remodelling and angiogenesis in non-cardiac inflammatory
diseases. Aim was to quantitate plasma YKL-40 in patients with ST-elevation myocardial …

Objectives : The objective of this meta-analysis was to evaluate the effect of stem cell
mobilization by granulocyte colony-stimulating factor (G-CSF) on myocardial regeneration on the …

The somatostatin receptor subtype 2 is expressed on macrophages, an abundant cell type
in the atherosclerotic plaque. Visualization of somatostatin receptor subtype 2, for oncologic …

Background A widespread modulation of gene expression occurs in the aging brain, but
little is known as to the upstream drivers of these changes. MicroRNAs emerged as fine …